Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2017 Filed Sep 15, 2017 22:37 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 100 | $51.28 | $5,127.50 |
DisclosureSEC source: 0001209191-17-053055 · doc4.xml · nonDerivative · entry 5 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Partnership Disclosed balance after: 133,784 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 22:37 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 318 | $51.75 | $16,456.50 |
DisclosureSEC source: 0001209191-17-053055 · doc4.xml · nonDerivative · entry 4 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Partnership Disclosed balance after: 133,884 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 22:37 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 2,500 | $52.13 | $130,325.00 |
DisclosureSEC source: 0001209191-17-053055 · doc4.xml · nonDerivative · entry 3 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,283,655 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $51.95 to $52.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 22:37 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 11,500 | $51.52 | $592,480.00 |
DisclosureSEC source: 0001209191-17-053055 · doc4.xml · nonDerivative · entry 2 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,286,155 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $50.95 to $51.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 22:37 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 4,900 | $50.33 | $246,617.00 |
DisclosureSEC source: 0001209191-17-053055 · doc4.xml · nonDerivative · entry 1 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,297,655 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $49.60 to $50.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 22:38 UTC |
RIGGS RORY BDirector
|
SaleCommon Stock | 25,000 | $51.92 | $1,298,000.00 |
DisclosureSEC source: 0001209191-17-053056 · doc4.xml · nonDerivative · entry 1 RIGGS RORY B · CIK 0001016835 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,200 F1 · price: The shares were sold at prices ranging from $51.50 to $52.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:23 UTC |
Cotroneo PatVP, Finance and CFO
|
SaleCommon Stock | 2,851 | $49.45 | $140,981.95 |
DisclosureSEC source: 0001209191-17-052698 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,405 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 00:37 UTC |
Yu K PeonyChief Medical Officer
|
Tax withholdingCommon Stock | 1,151 | $48.10 | $55,363.10 |
DisclosureSEC source: 0001209191-17-051811 · doc4.xml · nonDerivative · entry 2 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,397 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 00:36 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 3,261 | $48.10 | $156,854.10 |
DisclosureSEC source: 0001209191-17-051810 · doc4.xml · nonDerivative · entry 2 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,302,555 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 00:01 UTC |
Cotroneo PatVP, Finance and CFO
|
Tax withholdingCommon Stock | 1,151 | $48.10 | $55,363.10 |
DisclosureSEC source: 0001209191-17-051803 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,256 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 01:27 UTC |
Routti JormaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001209191-17-051481 · doc4.xml · derivative · entry 6 Routti Jorma · CIK 0001621330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2019-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 01:27 UTC |
Routti JormaDirector
|
SaleCommon Stock | 6,000 | $47.93 | $287,580.00 |
DisclosureSEC source: 0001209191-17-051481 · doc4.xml · nonDerivative · entry 4 Routti Jorma · CIK 0001621330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,840 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 01:27 UTC |
Routti JormaDirector
|
Exercise / conversionCommon Stock | 6,000 | $3.60 | $21,600.00 |
DisclosureSEC source: 0001209191-17-051481 · doc4.xml · nonDerivative · entry 3 Routti Jorma · CIK 0001621330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2017 Filed Sep 7, 2017 00:37 UTC |
Yu K PeonyChief Medical Officer
|
Tax withholdingCommon Stock | 1,959 | $49.00 | $95,991.00 |
DisclosureSEC source: 0001209191-17-051811 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,548 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 01, 2017 Filed Sep 7, 2017 00:36 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 4,688 | $49.00 | $229,712.00 |
DisclosureSEC source: 0001209191-17-051810 · doc4.xml · nonDerivative · entry 1 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,305,816 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 01, 2017 Filed Sep 7, 2017 00:01 UTC |
Cotroneo PatVP, Finance and CFO
|
Tax withholdingCommon Stock | 1,959 | $49.00 | $95,991.00 |
DisclosureSEC source: 0001209191-17-051803 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,407 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| August 31, 2017 Filed Sep 6, 2017 01:27 UTC |
Routti JormaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001209191-17-051481 · doc4.xml · derivative · entry 5 Routti Jorma · CIK 0001621330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2019-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 31, 2017 Filed Sep 6, 2017 01:27 UTC |
Routti JormaDirector
|
SaleCommon Stock | 6,000 | $46.78 | $280,680.00 |
DisclosureSEC source: 0001209191-17-051481 · doc4.xml · nonDerivative · entry 2 Routti Jorma · CIK 0001621330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,840 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| August 31, 2017 Filed Sep 6, 2017 01:27 UTC |
Routti JormaDirector
|
Exercise / conversionCommon Stock | 6,000 | $3.60 | $21,600.00 |
DisclosureSEC source: 0001209191-17-051481 · doc4.xml · nonDerivative · entry 1 Routti Jorma · CIK 0001621330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 23:51 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,524 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001209191-17-050828 · doc4.xml · derivative · entry 11 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,800 Underlying: Common Stock · 17,524 shares Expires 2018-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 23:51 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 418 | $44.64 | $18,659.52 |
DisclosureSEC source: 0001209191-17-050828 · doc4.xml · nonDerivative · entry 7 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Partnership Disclosed balance after: 134,202 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F6 · price: The shares were sold at prices ranging from $44.45 to $44.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 23:51 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 15,800 | $44.60 | $704,680.00 |
DisclosureSEC source: 0001209191-17-050828 · doc4.xml · nonDerivative · entry 6 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,310,504 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $44.00 to $44.975. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 23:51 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 3,100 | $43.43 | $134,633.00 |
DisclosureSEC source: 0001209191-17-050828 · doc4.xml · nonDerivative · entry 5 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,326,304 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $43.05 to $43.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 23:51 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 17,524 | $2.35 | $41,181.40 |
DisclosureSEC source: 0001209191-17-050828 · doc4.xml · nonDerivative · entry 4 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,329,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 23:51 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,900 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001209191-17-050828 · doc4.xml · derivative · entry 10 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,324 Underlying: Common Stock · 18,900 shares Expires 2018-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 23:51 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 418 | $43.10 | $18,015.80 |
DisclosureSEC source: 0001209191-17-050828 · doc4.xml · nonDerivative · entry 3 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Partnership Disclosed balance after: 134,620 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $42.85 to $43.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 23:51 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 18,900 | $43.04 | $813,456.00 |
DisclosureSEC source: 0001209191-17-050828 · doc4.xml · nonDerivative · entry 2 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,311,880 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $42.80 to $43.425. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 23:51 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 18,900 | $2.35 | $44,415.00 |
DisclosureSEC source: 0001209191-17-050828 · doc4.xml · nonDerivative · entry 1 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,330,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 22:47 UTC |
Yu K PeonyChief Medical Officer
|
SaleCommon Stock | 7,500 | $41.03 | $307,725.00 |
DisclosureSEC source: 0001209191-17-050006 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,507 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $40.60 to $41.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 17, 2017 Filed Sep 20, 2017 23:56 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 2,000 | $40.74 | $81,480.00 |
DisclosureSEC source: 0001209191-17-053528 · doc4.xml · nonDerivative · entry 1 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · kind: Shares sold pursuant to a 10b5-1 Plan. F2 · price: The shares were sold at prices ranging from $40.70 to $40.7501. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC |
Cotroneo PatVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · derivative · entry 7 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,254 Underlying: Common Stock · 85,000 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC |
Cotroneo PatVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · derivative · entry 6 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 10,000 shares Expires 2021-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC |
Cotroneo PatVP, Finance and CFO
|
SaleCommon Stock | 5,707 | $51.28 | $292,654.96 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · nonDerivative · entry 5 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,366 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $51.20 to $51.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC |
Cotroneo PatVP, Finance and CFO
|
SaleCommon Stock | 78,304 | $50.69 | $3,969,229.76 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,073 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $50.20 to $51.175. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC |
Cotroneo PatVP, Finance and CFO
|
SaleCommon Stock | 10,989 | $49.70 | $546,153.30 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,377 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $49.20 to $50.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC |
Cotroneo PatVP, Finance and CFO
|
Exercise / conversionCommon Stock | 85,000 | $14.58 | $1,238,875.00 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC |
Cotroneo PatVP, Finance and CFO
|
Exercise / conversionCommon Stock | 10,000 | $3.50 | $35,000.00 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:16 UTC |
Yu K PeonyChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-17-048481 · doc4.xml · derivative · entry 4 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,000 Underlying: Common Stock · 20,000 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:16 UTC |
Yu K PeonyChief Medical Officer
|
SaleCommon Stock | 5,100 | $51.11 | $260,661.00 |
DisclosureSEC source: 0001209191-17-048481 · doc4.xml · nonDerivative · entry 3 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,007 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $51.00 to $51.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:16 UTC |
Yu K PeonyChief Medical Officer
|
SaleCommon Stock | 32,400 | $50.50 | $1,636,200.00 |
DisclosureSEC source: 0001209191-17-048481 · doc4.xml · nonDerivative · entry 2 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,107 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $50.10 to $50.975. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:16 UTC |
Yu K PeonyChief Medical Officer
|
Exercise / conversionCommon Stock | 20,000 | $14.58 | $291,500.00 |
DisclosureSEC source: 0001209191-17-048481 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 00:16 UTC |
Cotroneo PatVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,446 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · derivative · entry 10 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,254 Underlying: Common Stock · 9,446 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 00:16 UTC |
Cotroneo PatVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,300 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · derivative · entry 9 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,300 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 00:16 UTC |
Cotroneo PatVP, Finance and CFO
|
SaleCommon Stock | 20,746 | $34.13 | $708,060.98 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · nonDerivative · entry 6 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,366 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $34.00 to $34.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 00:16 UTC |
Cotroneo PatVP, Finance and CFO
|
Exercise / conversionCommon Stock | 9,446 | $14.58 | $137,675.45 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · nonDerivative · entry 5 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 00:16 UTC |
Cotroneo PatVP, Finance and CFO
|
Exercise / conversionCommon Stock | 11,300 | $2.90 | $32,770.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:18 UTC |
Yu K PeonyChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-17-047556 · doc4.xml · derivative · entry 3 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,000 Underlying: Common Stock · 10,000 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:18 UTC |
Yu K PeonyChief Medical Officer
|
SaleCommon Stock | 10,000 | $33.48 | $334,800.00 |
DisclosureSEC source: 0001209191-17-047556 · doc4.xml · nonDerivative · entry 2 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,507 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $33.45 to $34.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:18 UTC |
Yu K PeonyChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $14.58 | $145,750.00 |
DisclosureSEC source: 0001209191-17-047556 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:16 UTC |
Cotroneo PatVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · derivative · entry 8 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,700 Underlying: Common Stock · 300 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.